Barclays Maintains Overweight on Aptiv, Lowers Price Target to $60

Benzinga Newsdesk www.benzinga.com Negative 78.7%

Neg 78.7% Neu 0% Pos 0%

Barclays analyst Dan Levy maintains Aptiv (NYSE:APTV) with a Overweight and lowers the price target from $65 to $60.

Comments

No comments yet. Be the first!